Advertisement
Screener

ELEVANCE HEALTH, INC. (ELV) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings

2.8 / 5 stars · 66/120 Roast Me

ELEVANCE HEALTH, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings

ELEVANCE HEALTH, INC. (ELV) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings of -$6.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.

Financial Statements › Income Statement › Other Income

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 · last filed 2026-02-06

  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2023-12-31 was -$3.00M.
  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2023-09-30 was $0.00.
  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2023-06-30 was $1.00M.
  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2023-03-31 was -$7.00M, a 275.00% decline year-over-year.
  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2025 was -$6.00M.
  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2024 was -$5.00M.
  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2023 was -$14.00M.
  • ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2022 was -$1.00M, a 105.26% decline from fiscal 2021.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 3 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 6 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 9 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 month as first filed
2025-12-31-$6.00M
10-K · filed 2026-02-06
2024-12-31-$5.00M
10-K · filed 2026-02-06
2023-12-31-$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06
-$3.00M
derived: sum of 2 quarters · filed 2026-02-06
-$2.00M
derived: sum of 3 quarters · filed 2026-02-06
-$14.00M
10-K · filed 2026-02-06
2023-09-30$0.00
10-Q · filed 2023-10-18
$1.00M
derived: sum of 2 quarters · filed 2023-10-18
-$11.00M
10-Q · filed 2023-10-18
-$8.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$1.00M
10-Q/A · filed 2023-09-29
-$7.00M
10-Q/A · filed 2023-09-29
-$8.00M
derived: sum of 3 quarters · filed 2025-02-20
-$8.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31-$7.00M
10-Q · filed 2023-04-19
-$9.00M
derived: sum of 2 quarters · filed 2025-02-20
-$9.00M
derived: sum of 3 quarters · filed 2025-02-20
-$16.00M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
-$2.00M
derived: sum of 2 quarters · filed 2025-02-20
-$9.00M
derived: sum of 3 quarters · filed 2025-02-20
-$1.00M
10-K · filed 2025-02-20
2022-09-30$0.00
10-Q · filed 2023-10-18
-$7.00M
derived: sum of 2 quarters · filed 2023-10-18
$1.00M
10-Q · filed 2023-10-18
-$3.00M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30-$7.00M
10-Q/A · filed 2023-09-29
-$3.00M
10-Q/A · filed 2023-09-29
-$3.00M
derived: sum of 3 quarters · filed 2024-02-21
$3.00M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$4.00M
10-Q · filed 2023-04-19
$4.00M
derived: sum of 2 quarters · filed 2024-02-21
$10.00M
derived: sum of 3 quarters · filed 2024-02-21
$15.00M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$6.00M
derived: sum of 2 quarters · filed 2024-02-21
$11.00M
derived: sum of 3 quarters · filed 2024-02-21
$19.00M
10-K · filed 2024-02-21
2021-09-30$6.00M
10-Q · filed 2022-10-19
$11.00M
derived: sum of 2 quarters · filed 2022-10-19
$19.00M
10-Q · filed 2022-10-19
$18.00M
derived: sum of 4 quarters · filed 2023-10-18
2021-06-30$5.00M
10-Q · filed 2022-07-20
$13.00M
10-Q · filed 2022-07-20
$12.00M
derived: sum of 3 quarters · filed 2023-10-18
$8.00M
derived: sum of 4 quarters · filed 2023-10-18
2021-03-31$8.00M
10-Q · filed 2022-04-20
$7.00M
derived: sum of 2 quarters · filed 2023-10-18
$3.00M
derived: sum of 3 quarters · filed 2023-10-18
-$6.00M
derived: sum of 4 quarters · filed 2023-10-18
2020-12-31-$1.00M
derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18
-$5.00M
derived: sum of 2 quarters · filed 2023-10-18
-$14.00M
derived: sum of 3 quarters · filed 2023-10-18
-$22.00M
10-Q · filed 2023-10-18
2020-09-30-$4.00M
10-Q · filed 2021-10-20
-$13.00M
derived: sum of 2 quarters · filed 2021-10-20
-$21.00M
10-Q · filed 2021-10-20
-$22.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30-$9.00M
10-Q · filed 2021-07-21
-$17.00M
10-Q · filed 2021-07-21
-$18.00M
derived: sum of 3 quarters · filed 2022-02-16
-$26.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31-$8.00M
10-Q · filed 2021-04-21
-$9.00M
derived: sum of 2 quarters · filed 2022-02-16
-$17.00M
derived: sum of 3 quarters · filed 2022-02-16
-$18.00M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
-$9.00M
derived: sum of 2 quarters · filed 2022-02-16
-$10.00M
derived: sum of 3 quarters · filed 2022-02-16
-$13.00M
10-K · filed 2022-02-16
2019-09-30-$8.00M
10-Q · filed 2020-10-28
-$9.00M
derived: sum of 2 quarters · filed 2020-10-28
-$12.00M
10-Q · filed 2020-10-28
-$13.00M
derived: sum of 4 quarters · filed 2021-02-18
2019-06-30-$1.00M
10-Q · filed 2020-07-29
-$4.00M
10-Q · filed 2020-07-29
-$5.00M
derived: sum of 3 quarters · filed 2021-02-18
-$1.00M
derived: sum of 4 quarters · filed 2021-02-18
2019-03-31-$3.00M
10-Q · filed 2020-04-29
-$4.00M
derived: sum of 2 quarters · filed 2021-02-18
$0.00
derived: sum of 3 quarters · filed 2021-02-18
$8.00M
derived: sum of 4 quarters · filed 2021-02-18
2018-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18
$3.00M
derived: sum of 2 quarters · filed 2021-02-18
$11.00M
derived: sum of 3 quarters · filed 2021-02-18
-$228.00M
10-K · filed 2021-02-18
2018-09-30$4.00M
10-Q · filed 2019-10-23
$12.00M
derived: sum of 2 quarters · filed 2019-10-23
-$227.00M
10-Q · filed 2019-10-23
-$227.00M
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$8.00M
10-Q · filed 2019-07-24
$8.10M
10-Q · filed 2018-07-25
-$231.00M
10-Q · filed 2019-07-24
-$230.90M
10-Q · filed 2018-07-25
-$231.00M
derived: sum of 3 quarters · filed 2020-02-19
-$231.00M
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31-$239.00M
10-Q · filed 2019-04-24
-$239.00M
derived: sum of 2 quarters · filed 2020-02-19
-$239.00M
derived: sum of 3 quarters · filed 2020-02-19
-$238.60M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$0.00
derived: sum of 2 quarters · filed 2020-02-19
$400.00K
derived: sum of 3 quarters · filed 2020-02-19
-$1.00M
10-K · filed 2020-02-19
2017-09-30$0.00
10-Q · filed 2018-10-31
-$500.00K
10-Q · filed 2017-10-25
$400.00K
derived: sum of 2 quarters · filed 2018-10-31
-$1.00M
10-Q · filed 2018-10-31
-$1.10M
10-Q · filed 2017-10-25
-$2.70M
derived: sum of 4 quarters · filed 2019-02-20
2017-06-30$400.00K
10-Q · filed 2018-07-25
-$600.00K
10-Q · filed 2018-07-25
-$2.70M
derived: sum of 3 quarters · filed 2019-02-20
-$3.20M
derived: sum of 4 quarters · filed 2019-02-20
2017-03-31-$1.00M
10-Q · filed 2018-04-25
-$3.10M
derived: sum of 2 quarters · filed 2019-02-20
-$3.60M
derived: sum of 3 quarters · filed 2019-02-20
-$4.30M
derived: sum of 4 quarters · filed 2019-02-20
2016-12-31-$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
-$2.60M
derived: sum of 2 quarters · filed 2019-02-20
-$3.30M
derived: sum of 3 quarters · filed 2019-02-20
-$2.00M
10-K · filed 2019-02-20
-$2.20M
10-K · filed 2017-02-22
2016-09-30-$500.00K
10-Q · filed 2017-10-25
-$1.20M
derived: sum of 2 quarters · filed 2017-10-25
$100.00K
10-Q · filed 2017-10-25
$1.90M
derived: sum of 4 quarters · filed 2018-02-21
2016-06-30-$700.00K
10-Q · filed 2017-07-26
$600.00K
10-Q · filed 2017-07-26
$2.40M
derived: sum of 3 quarters · filed 2018-02-21
$2.70M
derived: sum of 4 quarters · filed 2018-02-21
2016-03-31$1.30M
10-Q · filed 2017-04-26
$3.10M
derived: sum of 2 quarters · filed 2018-02-21
$3.40M
derived: sum of 3 quarters · filed 2018-02-21
$2.20M
derived: sum of 4 quarters · filed 2018-02-21
2015-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21
$2.10M
derived: sum of 2 quarters · filed 2018-02-21
$900.00K
derived: sum of 3 quarters · filed 2018-02-21
$100.00K
10-K · filed 2018-02-21
2015-09-30$300.00K
10-Q · filed 2016-11-02
-$900.00K
derived: sum of 2 quarters · filed 2016-11-02
-$1.70M
10-Q · filed 2016-11-02
$1.00M
derived: sum of 4 quarters · filed 2017-02-22
2015-06-30-$1.20M
10-Q · filed 2016-07-27
-$2.00M
10-Q · filed 2016-07-27
$700.00K
derived: sum of 3 quarters · filed 2017-02-22
-$32.30M
derived: sum of 4 quarters · filed 2017-02-22
2015-03-31-$800.00K
10-Q · filed 2016-04-27
$1.90M
derived: sum of 2 quarters · filed 2017-02-22
-$31.10M
derived: sum of 3 quarters · filed 2017-02-22
-$23.90M
derived: sum of 4 quarters · filed 2017-02-22
2014-12-31$2.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22
-$30.30M
derived: sum of 2 quarters · filed 2017-02-22
-$23.10M
derived: sum of 3 quarters · filed 2017-02-22
-$5.10M
10-K · filed 2017-02-22
2014-09-30-$33.00M
10-Q · filed 2015-10-28
-$25.80M
derived: sum of 2 quarters · filed 2015-10-28
-$7.80M
10-Q · filed 2015-10-28
-$25.90M
derived: sum of 4 quarters · filed 2016-02-19
2014-06-30$7.20M
10-Q · filed 2015-07-29
$25.20M
10-Q · filed 2015-07-29
$7.10M
derived: sum of 3 quarters · filed 2016-02-19
-$7.90M
derived: sum of 4 quarters · filed 2016-02-19
2014-03-31$18.00M
10-Q · filed 2015-04-29
-$100.00K
derived: sum of 2 quarters · filed 2016-02-19
-$15.10M
derived: sum of 3 quarters · filed 2016-02-19
-$18.10M
derived: sum of 4 quarters · filed 2016-02-19
2013-12-31-$18.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19
-$33.10M
derived: sum of 2 quarters · filed 2016-02-19
-$36.10M
derived: sum of 3 quarters · filed 2016-02-19
-$35.20M
10-K · filed 2016-02-19
2013-09-30-$15.00M
10-Q · filed 2014-10-29
-$18.00M
derived: sum of 2 quarters · filed 2014-10-29
-$17.10M
10-Q · filed 2014-10-29
-$17.60M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30-$3.00M
10-Q · filed 2014-07-30
-$2.10M
10-Q · filed 2013-07-24
-$2.60M
derived: sum of 3 quarters · filed 2015-02-24
-$3.00M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$900.00K
10-Q · filed 2014-04-30
$400.00K
derived: sum of 2 quarters · filed 2015-02-24
$0.00
derived: sum of 3 quarters · filed 2015-02-24
$400.00K
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31-$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
-$900.00K
derived: sum of 2 quarters · filed 2015-02-24
-$500.00K
derived: sum of 3 quarters · filed 2015-02-24
$14.40M
10-K · filed 2015-02-24
2012-09-30-$400.00K
10-Q · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2013-10-23
$14.90M
10-Q · filed 2013-10-23
2012-06-30$400.00K
10-Q · filed 2013-07-24
$15.30M
10-Q · filed 2013-07-24
2012-03-31$14.90M
10-Q · filed 2013-04-24
2011-12-31-$3.50M
10-K · filed 2014-02-20
2010-12-31-$13.40M
10-K · filed 2013-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cigna Group (CI)United States$70.160B10.44
HUMANA INC (HUM)United States$45.651B18.44
CENTENE CORP (CNC)United States$30.588B-6.22
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62